Protein arginine ( N )-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue FEBS Letters Année : 2008

Protein arginine ( N )-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins

Résumé

PRMT7 belongs to the protein arginine methyl-transferases family. We show that downregulation of PRMT7alpha and beta isoforms in DC-3F hamster cells was associated with increased sensitivity to the Top1 inhibitor camptothecin (CPT). This effect was not due to a change in Top1 contents or catalytic activity, or to a difference in the reversal of DNA breaks. Overexpression of PRMT7alpha and beta in DC-3F cells had no effect on CPT sensitivity, whereas it conferred a resistance to DC-3F/9-OH-E cells for which both isoforms are reduced by two- to three-fold as compared to DC-3F parental cells. Finally, downregulation of the human PRMT7 could also sensitize HeLa cells to CPT, suggesting that it could be used as a target to potentiate CPT derivatives.

Dates et versions

inserm-02438814 , version 1 (14-01-2020)

Identifiants

Citer

Vincent Verbiest, Danièle Montaudon, Michel Tautu, Joyce Moukarzel, Jean-Pierre Portail, et al.. Protein arginine ( N )-methyl transferase 7 (PRMT7) as a potential target for the sensitization of tumor cells to camptothecins. FEBS Letters, 2008, 582 (10), pp.1483-1489. ⟨10.1016/j.febslet.2008.03.031⟩. ⟨inserm-02438814⟩
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More